Management of MS-relapse during alemtuzumab therapy: Is it really B-cell-mediated?

Affiliations

• ¹ Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany.
• ² Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany.
• ³ Institute for Neuroradiology, Hannover Medical School, Hannover, Germany.
• ⁴ Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, Germany. Electronic address: Skripuletz.Thomas@MH-Hannover.de.